Table 2.
The correlation between presence of class 1 integeons and antibiotic resistance
| Antibiotics |
Isolated having integrons (n = 70)
|
Isolates lacking integrons (n = 30)
|
p-value* | ||||
|---|---|---|---|---|---|---|---|
| Susceptible NO (%) | Intermediate NO(%) | Resistant NO(%) | Susceptible NO (%) | Intermediate NO(%) | Resistant NO (%) | ||
| Ampicillin | 7 (10%) | 2 (2.58%) | 61 (87.14%) | 15 (50%) | 4 (13.33%) | 11(36.66%) | <0.001 |
| Amikacin | 50 (71.42%) | 14 (20%) | 6 (8.51%) | 19 (63.33%) | 6 (20%) | 5 (16.66%) | 0.4 |
| Ceftazidime | 32 (45.72%) | 5 (7.14%) | 33 (47.14%) | 16 (53.33%) | (0%) | 14 (46.66%) | 0.5 |
| Gentamicin | 56 (80%) | 2 (2.58%) | 12 (17.14%) | 15 (50%) | 7 (23.33%) | 8 (26.66%) | 0.008 |
| Ciprofloxacin | 24 (34.29%) | 1 (1.42%) | 45 (64.29%) | 21 (70%) | 4 (13.33) | 5 (16.66%) | <0.001 |
| Co-trimoxazole | 11 (15.71%) | 0 (0%) | 59 (84.28%) | 18 (60%) | 5 (16.66%) | 7 (23.33%) | <0.001 |
| Nalidixic acid | 17 (24.28%) | 3 (4.28%) | 50 (71.42%) | 14 (46.66%) | 4 (13.33%) | 12 (40%) | 0.005 |
| Cefotaxime | 28 (40%) | 0 (0%) | 42 (60%) | 15 (50%) | 0 (0%) | 15 (50%) | 0.3 |
*p < 0.05 is considered statistically significant.